Methotrexate at middle and high accumulative doses might be associated with lower risk of new-onset cancers in patients with rheumatoid arthritis: a nationwide population-based cohort study

BACKGROUND: We investigated whether taking methotrexate (MTX) is associated with a lower risk of new-onset cancers in patients with rheumatoid arthritis (RA). METHODS: We conducted a 12-year retrospective cohort study from a population-based National Health Insurance Research Database in Taiwan. A t...

Descripción completa

Detalles Bibliográficos
Autores principales: Perng, Wuu-Tsun, Hung, Yao-Min, Chang, Renin, Lin, Cheng-Li, Chiou, Jeng-Yuan, Chen, Huang-Hsi, Kao, Chia-Hung, Wei, James Cheng-Chung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7780328/
https://www.ncbi.nlm.nih.gov/pubmed/33447265
http://dx.doi.org/10.1177/1759720X20981221

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7780328/
https://www.ncbi.nlm.nih.gov/pubmed/33447265
http://dx.doi.org/10.1177/1759720X20981221

Ejemplares similares